Meg Marshall
2021
In 2021, Meg Marshall earned a total compensation of $3.2M as Chief Medical Officer at Barinthus Biotherapeutics plc..
Compensation breakdown
| Non-Equity Incentive Plan | $133,539 |
|---|---|
| Option Awards | $2,629,659 |
| Salary | $382,400 |
| Other | $32,033 |
| Total | $3,177,632 |
Marshall received $2.6M in option awards, accounting for 83% of the total pay in 2021.
Marshall also received $133.5K in non-equity incentive plan, $382.4K in salary and $32K in other compensation.
Rankings
In 2021, Meg Marshall's compensation ranked 4,209th out of 12,415 executives tracked by ExecPay. In other words, Marshall earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,209 out of 12,415 | 66th |
Division Manufacturing | 1,735 out of 5,508 | 69th |
Major group Chemicals And Allied Products | 723 out of 2,378 | 70th |
Industry group Drugs | 645 out of 2,099 | 69th |
Industry Pharmaceutical Preparations | 455 out of 1,549 | 71st |
Source: SEC filing on March 29, 2023.
Marshall's colleagues
We found one more compensation record of an executive who worked with Meg Marshall at Barinthus Biotherapeutics plc. in 2021.
2021
William Enright
Barinthus Biotherapeutics plc.